Predilife
Research Predilife (ALPRE) on Bullrun: market cap EUR 9.11M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerALPRE
- ExchangePA
- CountryFrance
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyEUR
- Market capEUR 9.11M
- Financial periodFY2024
- RevenueEUR 618.06K
- Revenue growth94.5%
- Net incomeEUR 198.63M
- Free cash flow-EUR 3.73M
- Gross margin97.8%
Valuation Snapshot
latest market cap is EUR 9.11M.
About Predilife
Predilife S.A. designs and markets predictive tests for the occurrence of serious illnesses. The company provides breast cancer predictive assessment; multi-pathology predictive assessment; and the Care4Eat solution, a nutrition assessment that allows employees to take stock of their eating habits and benefit from rebalancing and personalized advice. It also offers MammoRisk, a breast cancer prediction test based on the patient's individual risk; and DenSeeMammo, a breast density measurement software.
Frequently asked questions
What is Predilife's market cap?
Predilife's market capitalization is EUR 9.11M.
What does Predilife do?
Predilife S.A. designs and markets predictive tests for the occurrence of serious illnesses. The company provides breast cancer predictive assessment; multi-pathology predictive assessment;